Bay Area's Pionyr Immunotherapeutics Scores $62M to Push Anti-Tumor Tech Towards Clinic Post author:Sam Post published:December 12, 2017 Post category:BioPharma Pionyr was founded in 2015 by a UCSF professor and a Genentech alum. Source: BioSpace You Might Also Like There???s Lots of Work at the Top 10 World???s Largest Pharmaceutical Companies August 30, 2017 University at Albany Release: Biochemist's Technique Rapidly Detects Ebola Virus February 16, 2017 SanBio, Inc. Receives $20 Million Grant From For Stroke Clinical Trial July 4, 2017